Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route

Flibanserin (FLB) is a nonhormonal medicine approved by the Food and Drug Administration (FDA) to treat the hypoactive sexual appetite disorder in females. However, the peroral administration of the medicine is greatly affected by its poor bioavailability as a result of its extensive first-pass effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Osama A. A., A. Fahmy, Usama, Badr-Eldin, Shaimaa M., Aldawsari, Hibah M., Awan, Zuhier A., Asfour, Hani Z., Kammoun, Ahmed K., Caruso, Giuseppe, Caraci, Filippo, Alfarsi, Anas, A. Al-Ghamdi, Raniyah, A. Al-Ghamdi, Rawan, Alhakamy, Nabil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408465/
https://www.ncbi.nlm.nih.gov/pubmed/32610539
http://dx.doi.org/10.3390/nano10071270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408465/
https://www.ncbi.nlm.nih.gov/pubmed/32610539
http://dx.doi.org/10.3390/nano10071270

Ejemplares similares